Gallmetzer Healthcare H1 FY26 EBIT climbs to EUR 453,754; EBITDA totals EUR 1.02 million

Reuters2026/09/03 13:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Gallmetzer Healthcare posted EBITDA of EUR 1.02 million for the first half ended June 30, 2026, on revenue of EUR 34.53 million.
EBIT reached EUR 453,754, with EBITDA margin at 3.18% of value of production.
Revenue rose about 6% versus the first half of the prior year, supported by stronger margins across the group.
Gerhò turnover increased 5.45% with margins up 1.72%, while Promis revenue climbed 3.5% on wider international distribution.
Intermedical Pharma completed refurbishment of its anaesthetics production site, moving into the machinery-ordering phase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gallmetzer Healthcare S.p.A. published the original content used to generate this news brief on September 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Gallmetzer Healthcare H1 FY26 EBIT climbs to EUR 453,754; EBITDA totals EUR 1.02 million

You may also like

Crypto prices